Recently, Xiao and colleagues revealed that 10 mmol/L of metformin, an oral antihyperglycemic used to treat type 2 diabetes mellitus, attenuates the expression of INHBA and inhibits the proliferation of colorectal cancer cells (56). The gene discussed is INHBA; the disease is type 2 diabetes mellitus.